Vaccinating 130Cr people with injectable Covaxin a challenge: Bharat Biotech
Even as India's first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday raised the logistical query on "how to vaccinate 1.3 billion (130 crore) people with two injectable doses.…